Sotera Health Enters Material Definitive Agreement
Ticker: SHC · Form: 8-K · Filed: Sep 18, 2025 · CIK: 1822479
| Field | Detail |
|---|---|
| Company | Sotera Health Co (SHC) |
| Form Type | 8-K |
| Filed Date | Sep 18, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $1,423,029,875, $75,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation
Related Tickers: SH
TL;DR
Sotera Health just signed a big deal, creating new financial obligations.
AI Summary
Sotera Health Company entered into a material definitive agreement on September 17, 2025. This agreement also creates a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant new agreement for Sotera Health, which could impact its financial obligations and future operations.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements and creating new financial obligations can introduce financial and operational risks.
Key Players & Entities
- Sotera Health Company (company) — Registrant
- September 17, 2025 (date) — Date of Earliest Event Reported
FAQ
What type of material definitive agreement did Sotera Health Company enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on September 17, 2025.
What are the specific financial obligations created by this agreement?
The filing states that the agreement creates a direct financial obligation or an obligation under an off-balance sheet arrangement, but does not detail the specific amounts or terms.
Is this agreement related to any acquisitions or divestitures?
The filing does not provide details about the purpose of the agreement, so it is not possible to determine if it relates to acquisitions or divestitures.
What is the expected impact of this agreement on Sotera Health's financial statements?
The filing indicates the creation of financial obligations, suggesting a potential impact on the balance sheet and income statement, but specific details are not provided.
When was this agreement officially reported?
This current report was filed on September 18, 2025, with the earliest event reported being September 17, 2025.
Filing Stats: 800 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2025-09-18 17:01:56
Key Financial Figures
- $0.01 — nge on which registered Common stock, $0.01 par value per share SHC The Nasdaq
- $1,423,029,875 — SHH in an aggregate principal amount of $1,423,029,875, which reflects the balance after the C
- $75,000,000 — ance after the Company's application of $75,000,000 of available cash to repay outstanding
Filing Documents
- d45811d8k.htm (8-K) — 28KB
- d45811dex101.htm (EX-10.1) — 1309KB
- 0001193125-25-207549.txt ( ) — 1767KB
- shc-20250917.xsd (EX-101.SCH) — 3KB
- shc-20250917_lab.xml (EX-101.LAB) — 18KB
- shc-20250917_pre.xml (EX-101.PRE) — 11KB
- d45811d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 10.1 Amendment No. 6, dated as of September 17, 2025, to the First Lien Credit Agreement dated as of December 13, 2019 by and among Sotera Health Company, Sotera Health Holdings, LLC, certain subsidiaries of Sotera Health Company, JPMorgan Chase Bank, N.A., as First Lien Administrative Agent, and the 2025 Refinancing Term Lenders party thereto. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sotera Health Company (Registrant) Date: September 18, 2025 By: /s/ Jonathan M. Lyons Jonathan M. Lyons Senior Vice President and Chief Financial Officer